Form 4: Avanos Medical CFO Michael Greiner Sells Shares to Cover Tax Obligations

Michael Greiner, SVP and CFO of Avanos Medical, sold 8,000 shares of common stock on March 14, 2024, to cover tax obligations from vested restricted share units.

Summary

• Michael Greiner, the SVP and CFO of Avanos Medical, sold 8,000 shares of the company's common stock on March 14, 2024.
• The sales were executed in multiple transactions at prices ranging from $19.11 to $19.16 per share.
• Following these transactions, Greiner directly owns 151,495 shares of Avanos Medical.
• The purpose of the sale was to cover tax obligations resulting from the vesting of 61,472 time-based restricted share units (TRSUs) on January 2, 2023, March 4, 2023, and May 7, 2023.
• Greiner has stated that he was not in possession of material non-public information at the time of the sale.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The sale is for tax purposes and the CFO claims no inside information was used.

Positives

• The CFO's sale is attributed to covering tax obligations from vested shares, which is a common and understandable reason for selling stock.
• The CFO has stated that he was not in possession of material non-public information at the time of the sale.

Management Comments

• Michael Greiner stated that he intends to use the proceeds from the sale of shares to satisfy tax obligations resulting from the vesting of the Vested TRSUs.
• Michael Greiner stated that he was not in possession of material non-public information regarding the Issuer at the time of such sale.

Industry Context

Insider sales are a common occurrence, and this transaction appears to be related to tax obligations rather than a change in the CFO's outlook on the company.

Stakeholder Impact

• The sale of shares by a high-ranking officer could cause short-term fluctuations in the stock price, but the stated reason mitigates potential negative sentiment.

Key Dates